Drug firm Teva predicts 2017 revenue and profit below estimates
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
Teva Pharma: Your Brief On The Big Earnings Report Coming In February (NYSE: TEVA) | Seeking Alpha
Is TEVA a Pain Before the Gain? – PGM Capital
TEVA Gears Up to Report Q4 Earnings: What's in the Cards?
Tear Sheet: Teva Pharmaceuticals Faces Pressure From Competing Generics, Seeks to Delever Quickly After Actavis Acquisition - Reorg
/cloudfront-us-east-2.images.arcpublishing.com/reuters/5OMAQFWFHNJDZCDZKKO5DWLBG4.jpg "Teva, affiliates ignored safety to boost opioid sales, jury told | Reuters")
Teva, affiliates ignored safety to boost opioid sales, jury told | Reuters
Form 6-K
What Kind Of Investor Owns Most Of Teva Pharmaceutical Industries Limited (NYSE:TEVA)?
Teva Pharmaceutical net income 2006-2020 | Statista
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
Tear Sheet: Teva Pharmaceuticals Faces Pressure From Competing Generics, Seeks to Delever Quickly After Actavis Acquisition - Reorg
Is Teva Pharmaceutical Industries (NYSE:TEVA) Using Too Much Debt? | Nasdaq
Teva Pharmaceutical's (NYSE: TEVA) Ice-Cube Business Model | Seeking Alpha
Definitive Proxy Statement
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva Pharmaceutical Industries Limited - AnnualReports.com
Israel's ailing Teva to cut 25% of global workforce in recovery effort | The Times of Israel
Teva Pharmaceutical Industries Limited - AnnualReports.com
Teva Pharmaceutical Industries Ltd 2019 Annual Report 10-K
Teva Reports Third Quarter 2021 Financial Results
Teva Pharmaceutical Industries Stock Gives Every Indication Of Being Modestly Undervalued
New branded drugs helping Teva Pharm move closer to growth | Reuters
